Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 2
2005 3
2006 2
2007 1
2008 3
2009 11
2010 8
2011 11
2012 11
2013 6
2014 4
2015 12
2016 17
2017 25
2018 20
2019 18
2020 15
2021 28
2022 17
2023 12
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

191 results

Results by year

Filters applied: . Clear all
Page 1
Gastric neuroendocrine neoplasms.
Lamberti G, Panzuto F, Pavel M, O'Toole D, Ambrosini V, Falconi M, Garcia-Carbonero R, Riechelmann RP, Rindi G, Campana D. Lamberti G, et al. Among authors: pavel m. Nat Rev Dis Primers. 2024 Apr 11;10(1):25. doi: 10.1038/s41572-024-00508-y. Nat Rev Dis Primers. 2024. PMID: 38605021 Review.
Determinants Affecting the Clinical Implementation of a Molecularly Informed Molecular Tumor Board Recommendation: Experience from a Tertiary Cancer Center.
Tögel L, Schubart C, Lettmaier S, Neufert C, Hoyer J, Wolff K, Moskalev EA, Stöhr R, Agaimy A, Reis A, Wullich B, Mackensen A, Pavel M, Beckmann MW, Hartmann A, Fietkau R, Meidenbauer N, Haller F, Spoerl S. Tögel L, et al. Among authors: pavel m. Cancers (Basel). 2023 Dec 18;15(24):5892. doi: 10.3390/cancers15245892. Cancers (Basel). 2023. PMID: 38136436 Free PMC article.
Use and perceived utility of [18 F]FDG PET/CT in neuroendocrine neoplasms: A consensus report from the European Neuroendocrine Tumor Society (ENETS) Advisory Board Meeting 2022.
Ambrosini V, Caplin M, Castaño JP, Christ E, Denecke T, Deroose CM, Dromain C, Falconi M, Grozinsky-Glasberg S, Hicks RJ, Hofland J, Kjaer A, Knigge UP, Kos-Kudla B, Koumarianou A, Krishna B, Lamarca A, Pavel M, Reed NS, Scarpa A, Srirajaskanthan R, Sundin A, Toumpanakis C, Prasad V. Ambrosini V, et al. Among authors: pavel m. J Neuroendocrinol. 2024 Jan;36(1):e13359. doi: 10.1111/jne.13359. Epub 2023 Dec 14. J Neuroendocrinol. 2024. PMID: 38097193
Global challenges in access to diagnostics and treatment for neuroendocrine tumor (NET) patients.
Dureja S, McDonnell M, Van Genechten D, Bouvier C, Kolarova T, O'Toole D, Singh H, Chen J, Howe J, Singh S, Rodien-Louw C, Leyden S, Gellerman E, Herman J, Pavel M; International Neuroendocrine Cancer Alliance (INCA). Dureja S, et al. Among authors: pavel m. J Neuroendocrinol. 2023 Jun;35(6):e13310. doi: 10.1111/jne.13310. Epub 2023 Jun 23. J Neuroendocrinol. 2023. PMID: 37351944 Review.
Neuropathy in paediatric type 1 diabetes mellitus - clinical characterization and analysis of risk factors in the diabetes prospective follow-up registry DPV (Diabetes-Patienten-Verlaufsdokumentation)-registry.
Pappa A, Haeusler MG, Tittel SR, Boettcher C, Hilgard D, Knauer-Fischer S, Pavel M, Woelfle J, Holl RW. Pappa A, et al. Among authors: pavel m. J Pediatr Endocrinol Metab. 2023 Jun 12;36(7):628-635. doi: 10.1515/jpem-2023-0074. Print 2023 Jul 26. J Pediatr Endocrinol Metab. 2023. PMID: 37307302
Consensus report of the 2021 National Cancer Institute neuroendocrine tumor clinical trials planning meeting.
Singh S, Hope TA, Bergsland EB, Bodei L, Bushnell DL, Chan JA, Chasen BR, Chauhan A, Das S, Dasari A, Del Rivero J, El-Haddad G, Goodman KA, Halperin DM, Lewis MA, Lindwasser OW, Myrehaug S, Raj NP, Reidy-Lagunes DL, Soares HP, Strosberg JR, Kohn EC, Kunz PL; NET CTPM participants. Singh S, et al. J Natl Cancer Inst. 2023 Sep 7;115(9):1001-1010. doi: 10.1093/jnci/djad096. J Natl Cancer Inst. 2023. PMID: 37255328
191 results